V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Market Cap: 10.8B CHF
Have any thoughts about
Vifor Pharma AG?
Write Note

Vifor Pharma AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Income from Continuing Operations Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Income from Continuing Operations
CHf265.4m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
0%
Novartis AG
SIX:NOVN
Income from Continuing Operations
$10.1B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
1%
Roche Holding AG
SIX:ROG
Income from Continuing Operations
CHf12.4B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
1%
S
Sandoz Group AG
SIX:SDZ
Income from Continuing Operations
$80m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Income from Continuing Operations?
Income from Continuing Operations
265.4m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Income from Continuing Operations amounts to 265.4m CHF.

What is Vifor Pharma AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%

Over the last year, the Income from Continuing Operations growth was 12%. The average annual Income from Continuing Operations growth rates for Vifor Pharma AG have been 3% over the past three years , 3% over the past five years .

Back to Top